My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Contributor

Product Type

Location

Published Date

Displaying 4 results for

GO
Search Filters: Infectious Disease cancel Jessica Baggett cancel

State Legislatures Reshape Public Health Legal Authority

Blog,
Policy,
Public Health Law,
Health Policy Update,
State Health Policy,
Infectious Disease,
COVID-19,
COVID and Law/Policy,
Population Health and Prevention,
Social and Behavioral Health,
Tobacco Control,
Healthcare Access,
STIs,
HIV,
North Carolina,
South Carolina,
Hawaii,
Washington,
Texas,
Utah,
Kansas,
Idaho,
Oklahoma,
Wyoming,
New Hampshire,
Jessica Baggett,
Andy Baker-White,
Maggie Davis

Learn how state and territorial legislatures can bolster or restrict public health legal authority, with examples from early COVID-19 as well as 2024.

From the Chief Medical Officer: Key Takeaways from ASTHO’s HPAI Scientific Symposium

Blog,
People of Public Health,
Series,
Chief Medical Officer Series,
Infectious Disease,
Emerging Infectious Diseases,
Marcus Plescia,
Meredith Allen,
Jessica Baggett,
ASTHO Events

From the Chief Medical Officer: Key Takeaways from ASTHO’s HPAI Scientific Symposium hpai scientific symposium, highly pathogenic avian influenza, one health, public health, state and local public health officials, wild birds, human ...

Maximizing the Benefit of COVID-19 Therapeutics: Considerations for State Public Health Officials

Brief,
Infectious Disease,
COVID-19,
COVID and Communication,
COVID and Community Mitigation,
COVID and Funding,
COVID and Health Equity/Health Disparities,
COVID and Healthcare Systems,
COVID Recovery,
COVID Resilience,
COVID Vaccine,
COVID and Workforce,
Preparedness,
Health Equity,
Alaska,
Connecticut,
Minnesota,
Mississippi,
Oregon,
Partnership,
Marcus Plescia,
Jessica Baggett,
Katie Greene,
Katie Huber,
Matt D’Ambrosio,
Andrea Thoumi,
Mark McClellan

An issue brief by ASTHO and the Duke University Margolis Center for Health Policy that highlights considerations for state health officials as they look to maximize the benefits of COVID-19 therapeutics.